Congratulations to Luma, which can now move its technology further toward market.
Luma Therapeutics, Inc., a medical device company developing innovative technologies for inflammatory skin disease, announced today that it has raised $2 million in private financing with new and existing investors. The company will use the proceeds to continue collecting clinical evidence supporting its flagship product, the Luma Light System™, and preparing the system for commercial release.
In other news, Luma announced that Matt Likens, has joined its Board of Directors. Mr. Likens is a principal at Likens Healthcare and Management Consulting, LLC. He was the President and CEO of Ulthera, Inc. from 2006 to 2016. Prior to Ulthera, Mr. Likens was employed at GMP Companies, Inc. as President of GMP Wireless Medicine from 2001 to 2006 and Executive Vice President, Operations from 2001 to 2004. Mr. Likens previously served in various capacities at Baxter Healthcare Corporation from 1978 to 2001, and was President of Baxter’s Renal U.S. business upon his departure in January, 2001.